Clover Health Investments, Corp. - 8-K Summary
Business Context and Reporting Period
This Form 8-K reports on the results of the 2024 Annual Meeting of Stockholders held virtually on June 10, 2024. The filing details the voting outcomes for three proposals submitted to stockholders, including director elections, executive compensation approval, and auditor ratification.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance voting results.
Material Changes and Voting Results
Stockholders voted on three key proposals with the following certified results:
- Proposal 1: Election of Class III Directors
- Chelsea Clinton: 937,120,902 FOR; 26,227,596 WITHHELD.
- Carladenise Armbrister Edwards: 942,172,343 FOR; 21,176,155 WITHHELD.
- Vivek Garipalli: 941,392,586 FOR; 21,955,912 WITHHELD.
- All three nominees were elected to serve until the 2027 annual meeting.
- Proposal 2: Advisory Vote on Executive Compensation (Say-on-Pay)
- 950,591,272 FOR; 10,963,460 AGAINST; 1,793,766 ABSTAIN.
- The proposal to approve 2023 Named Executive Officer compensation was approved.
- Proposal 3: Ratification of Independent Auditor
- 1,100,958,512 FOR; 5,333,701 AGAINST; 2,267,858 ABSTAIN.
- Ernst & Young LLP was ratified as the independent registered public accounting firm for the fiscal year ending December 31, 2024.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for financial guidance, management outlook, specific risks, contingencies, or unusual items. The document is limited to the disclosure of voting results.
Key Facts for Investor Verification
- Verify the total number of shares entitled to vote as of the April 15, 2024 Record Date to contextualize the voting percentages.
- Confirm the specific terms of the 2023 executive compensation package referenced in Proposal 2 by reviewing the definitive proxy statement filed on April 26, 2024.
- Note the significant number of Broker Non-Votes (145,211,573) recorded for the director election and compensation proposals.
- Review the upcoming fiscal year 2024 financial reports to assess the company's operational performance, as this 8-K contains no financial data.